GOLD 2026 narrows LAMA monotherapy's niche in COPD, even as tiotropium Respimat, the class's only asthma-indicated agent, rests on the largest dedicated respiratory device safety trial ever run.

Adults hospitalised with COVID face a higher incidence of gastrointestinal bleeding than those not hospitalised.

Carotid near-occlusion is not linked to preoperative recurrent stroke or 30-day stroke or death after carotid endarterectomy ...

Respiratory tract infections (RTIs), especially pneumonia and COVID, significantly increased the risk for cardiovascular ...

Research reveals age-related weakness stems from broken nerve-muscle signals — and a drug target already in human trials can ...

Children with cannabis exposure often present with neurologic signs such as lethargy, irritability, and reduced ...

Opioid-naïve patients on higher-dose opioids for acute low back pain have a higher risk for opioid use disorder or overdose, ...

Experts say regulatory and economic hurdles are slowing European access to innovative psychiatric drugs despite rising unmet ...

Interest in wearables is growing among people with gastrointestinal (GI) conditions. In one study of 400 adults with ...

Students describe unequal treatment during clinical training, raising concerns about how workplace culture and senior ...

GINA 2026 no longer endorses a SABA alone for asthma, yet albuterol labels still list only bronchospasm. Airsupra adds exacerbation risk reduction for adults.

Structured support, such as a digital wellness app or medically tailored meals, may help curb weight regain in the first 4 ...